TapewireFind a company

person · Reporting owner

Carruthers Wendy

Disclosed activity across 2 companies

Tapewire entity
45122
SEC CIK
0001563565

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BOSTON SCIENTIFIC CORPBSX · Entity 1897EVP, Human ResourcesDecember 02, 2024December 04, 2024
Envista Holdings CorpNVST · Entity 4007DirectorMay 19, 2026May 21, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BOSTON SCIENTIFIC CORP

Report date December 02, 2024 · Filed December 04, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect29,308 Ending reported balance After 2024-12-02 transaction · row 3
3 source rows · reconciled sequence

Row 1 · 2024-12-02 · Exercise / conversion · Acquired 3,066 · Balance 35,094

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Row 2 · 2024-12-02 · Exercise / conversion · Acquired 1,197 · Balance 36,291

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Row 3 · 2024-12-02 · Sale · Disposed 6,983 · Balance 29,308

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.26 · Expires 2026-02-22Direct0 Reported balance After 2024-12-02 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2024-12-02 · Exercise / conversion · Disposed 3,066 · Balance 0

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.55 · Expires 2027-02-28Direct13,183 Reported balance After 2024-12-02 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2024-12-02 · Exercise / conversion · Disposed 1,197 · Balance 13,183

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Envista Holdings Corp

Report date May 19, 2026 · Filed May 21, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect59,940 Reported balance After 2026-05-19 transaction · row 1
1 source row

Row 1 · 2026-05-19 · Grant · Acquired 9,330 · Balance 59,940

F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Filing footnotes · ownership attribution and instrument terms

F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 19, 2026 Filed May 21, 2026 20:37 UTC Envista Holdings Corp NVST · Entity 4007 GrantCommon Stock 9,330 $0.00 $0.00
Disclosure

SEC source: 0001563565-26-000003 · wk-form4_1779395847.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,940

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:55 UTC Envista Holdings Corp NVST · Entity 4007 GrantCommon Stock 10,450 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-031064 · wk-form4_1749761718.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,610

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 21:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-010528 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,183

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 21:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-010528 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 21:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 SaleCommon Stock 6,983 $90.78 $633,916.74
Disclosure

SEC source: 0001225208-24-010528 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,308

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 21:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-010528 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,291

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 21:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-010528 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,094

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
November 01, 2024 Filed Nov 4, 2024 21:09 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-009605 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,380

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
November 01, 2024 Filed Nov 4, 2024 21:09 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-009605 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,066

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
November 01, 2024 Filed Nov 4, 2024 21:09 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 SaleCommon Stock 6,983 $84.33 $588,876.39
Disclosure

SEC source: 0001225208-24-009605 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,028

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
November 01, 2024 Filed Nov 4, 2024 21:09 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-009605 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,011

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
November 01, 2024 Filed Nov 4, 2024 21:09 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-009605 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,814

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:22 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-009021 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,577

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:22 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-009021 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,132

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:22 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 SaleCommon Stock 6,983 $83.86 $585,594.38
Disclosure

SEC source: 0001225208-24-009021 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,748

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:22 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-009021 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,731

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:22 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-009021 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,534

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
September 03, 2024 Filed Sep 3, 2024 21:29 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-008333 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,774

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
September 03, 2024 Filed Sep 3, 2024 21:29 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-008333 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,198

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
September 03, 2024 Filed Sep 3, 2024 21:29 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 SaleCommon Stock 6,983 $81.70 $570,511.10
Disclosure

SEC source: 0001225208-24-008333 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,468

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
September 03, 2024 Filed Sep 3, 2024 21:29 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-008333 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
September 03, 2024 Filed Sep 3, 2024 21:29 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-008333 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,254

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 21:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-007778 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,971

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 21:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-007778 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,264

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 21:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 SaleCommon Stock 6,983 $74.12 $517,579.96
Disclosure

SEC source: 0001225208-24-007778 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,188

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 21:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-007778 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,171

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 21:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-007778 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,974

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-007196 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,168

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-007196 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,330

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 SaleCommon Stock 6,983 $77.30 $539,785.90
Disclosure

SEC source: 0001225208-24-007196 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,908

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-007196 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-007196 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,694

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
June 03, 2024 Filed Jun 3, 2024 21:39 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-006513 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,365

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
June 03, 2024 Filed Jun 3, 2024 21:39 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-006513 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,396

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
June 03, 2024 Filed Jun 3, 2024 21:39 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 SaleCommon Stock 6,983 $75.33 $526,029.39
Disclosure

SEC source: 0001225208-24-006513 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,628

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
June 03, 2024 Filed Jun 3, 2024 21:39 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-006513 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,611

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
June 03, 2024 Filed Jun 3, 2024 21:39 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-006513 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:34 UTC Envista Holdings Corp NVST · Entity 4007 GrantCommon Stock 10,085 $0.00 $0.00
Disclosure

SEC source: 0001757073-24-000054 · wk-form4_1716496448.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,160

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 01, 2024 Filed May 2, 2024 20:42 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-005478 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,562

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
May 01, 2024 Filed May 2, 2024 20:42 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-005478 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,462

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
May 01, 2024 Filed May 2, 2024 20:42 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 SaleCommon Stock 6,983 $71.47 $499,075.01
Disclosure

SEC source: 0001225208-24-005478 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,348

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
May 01, 2024 Filed May 2, 2024 20:42 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-005478 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,331

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
May 01, 2024 Filed May 2, 2024 20:42 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-005478 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,134

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 22:57 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-004848 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,759

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 22:57 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-004848 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,528

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 22:57 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 SaleCommon Stock 6,983 $68.42 $477,776.86
Disclosure

SEC source: 0001225208-24-004848 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,068

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 22:57 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-004848 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,051

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 22:57 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-004848 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,854

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 23:50 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-003504 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,956

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 23:50 UTC BOSTON SCIENTIFIC CORP BSX · Entity 1897 Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-003504 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,594

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.